郑州微飒生物科技有限责任公司 咨询热线:0371-88821766
行业动态

行业动态

追踪行业前沿,洞察产业趋势

药效评价THRX-198321 is a bifunctional muscarinic receptor antagonist and beta2-adrenoceptor agonist (MABA) that binds in a bimodal and multivalent manner.

期刊:Molecular pharmacology发表年份:2011作者:Tod Steinfeld; Adam D Hughes; Uwe Klein; Jacqueline A M Smith; Mathai Mammen

药效评价Mechanism for noncompetitive inhibition by novel GluN2C/D N-methyl-D-aspartate receptor subunit-selective modulators.

期刊:Molecular pharmacology发表年份:2011作者:Timothy M Acker; Hongjie Yuan; Kasper B Hansen; Katie M Vance; Kevin K Ogden; Henrik S Jensen; Pieter B Burger; Praseeda Mullasseril; James P Snyder; Dennis C Liotta; Stephen F Traynelis

药效评价Pharmacological characterization of a novel α2C-adrenoceptor agonist N-[3,4-dihydro-4-(1H-imidazol-4-ylmethyl)-2H-1, 4-benzoxazin-6-yl]-N-ethyl-N'-methylurea (compound A).

期刊:The Journal of pharmacology and experimental therapeutics发表年份:2011作者:Michel R Corboz; Maria A Rivelli; Kevin D McCormick; Yuntao Wan; Himanshu Shah; Shelby Umland; Gisela Lieber; Yanlin Jia; Robbie L McLeod; Cynthia Morgan; Geoffrey B Varty; Jie Wu; Kung-I Feng; Christopher W Boyce; Robert G Aslanian; Jai Palamanda; A

药效评价The clozapine metabolite N-desmethylclozapine displays variable activity in diverse functional assays at human dopamine D₂ and serotonin 5-HT₁A receptors.

期刊:European journal of pharmacology发表年份:2011作者:Peter Heusler; Liesbeth Bruins Slot; Amélie Tourette; Stéphanie Tardif; Didier Cussac